Results:

New York, NY - February 1, 2005

Objectives

Prioritize critical, novel targets to be investigated for the development of potential therapies for the treatment of multiple myeloma.

Investigate providing grants for at least three projects for an initial 1-year period in the initial phase of the Therapeutic Targets initiative.

Sponsors

Celgene Corporation
Chiron Corporation
Millennium Pharmaceuticals